Researchers from the University of Adelaide have developed a new technology for drug and functional genomics screenings, ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC) space, began with its founders ...

It’s built a state-of-the-art drug design engine housed on Google Cloud with NVIDIA GPUs to enable the scale and performance needed to continue developing groundbreaking AI models that can help ...

More information: Prakash Jadhav et al, Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates, Nature Communications (2025). DOI: 10.1038/s41467-025-56902-x ...

However, traditional techniques for improving rAAV titers, such as Design of Experiment (DOE ... that the model predicted trends in viral vector formation but struggled to fit the cell density ...

Key enhancements include new front anti scratch bumpers, specific fog lights design, roof rails for additional cargo options and all-season Mud & Snow tires (Vector 4Seasons GEN-3 by Goodyear ...

Significant contributions to this study were made by Eddy Arnold’s Lab at Rutgers’ Center for Advanced Biotechnology and Medicine (CABM), which solved the X-ray crystal structures of PLpro—critical ...

The company is building what it describes as an AI drug design engine. The software reduces the amount of manual work involved in developing new medicines and thereby speeds up the process.

Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...